Dose ‐escalation strategies which use subgroup information
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - June 14, 2018 Category: Statistics Authors: AmyCotterill
,
ThomasJaki Source Type: research
SPIRIT: A seamless phase I/II randomized design for immunotherapy trials
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - June 8, 2018 Category: Statistics Authors: BeibeiGuo
,
DanielLi
,
YingYuan Source Type: research
Missing data handling in non ‐inferiority and equivalence trials: A systematic review
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - May 25, 2018 Category: Statistics Authors: Brooke A.Rabe
,
SimonDay
,
Mallorie H.Fiero
,
Melanie L.Bell Source Type: research
Investigation of mixed model repeated measures analyses and non ‐linear random coefficient models in the context of long‐term efficacy data
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - May 21, 2018 Category: Statistics Authors: BrunoDelafont
,
KevinCarroll
,
ClaireVilain
,
EmmanuelPham Source Type: research
Issue Information
Pharmaceutical Statistics,Volume 17, Issue 3, Page 199-201, May/June 2018. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - May 15, 2018 Category: Statistics Source Type: research
Equal ‐tailed confidence intervals for comparison of rates
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - May 4, 2018 Category: Statistics Authors: PeterLaud Source Type: research
Design and inference for 3 ‐stage bioequivalence testing with serial sampling data
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - May 4, 2018 Category: Statistics Authors: FangrongYan
,
HuihongZhu
,
JunlinLiu
,
LiyunJiang
,
XuelinHuang Source Type: research
Sample size determination and treatment screening in two ‐stage phase II clinical trials via ROC curve
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - May 3, 2018 Category: Statistics Authors: Wong ‐ShianHuang
,
Yuan‐chin IvanChang Source Type: research
Optimal planning of phase II/III programs for clinical trials with multiple endpoints
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - April 27, 2018 Category: Statistics Authors: MeinhardKieser
,
MariettaKirchner
,
EvaD ölger
,
HeikoGötte Source Type: research
BOIN ‐ET: Bayesian optimal interval design for dose finding based on both efficacy and toxicity outcomes
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - April 27, 2018 Category: Statistics Authors: KentaroTakeda
,
MasatakaTaguri
,
SatoshiMorita Source Type: research
Randomised Response ‐Adaptive Designs in Clinical Trials, First Edition Anthony C. Atkinson, Atanu Biswas (2014) Chapman & Hall/CRC Monographs on Statistics & Applied Probability ISBN: 9781584886938 No. of pages: 339 Price: $99.95 (USD)/ £71.99 (GBP)
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - April 24, 2018 Category: Statistics Authors: LaurenBell Source Type: research
Conditional estimation using prior information in 2 ‐stage group sequential designs assuming asymptotic normality when the trial terminated early
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - April 24, 2018 Category: Statistics Authors: MasashiShimura
,
KazushiMaruo
,
MasahikoGosho Source Type: research
Estimating the variance for heterogeneity in arm ‐based network meta‐analysis
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - April 20, 2018 Category: Statistics Authors: Hans ‐PeterPiepho
,
Laurence V.Madden
,
JamesRoger
,
RogerPayne
,
Emlyn R.Williams Source Type: research
How to use prior knowledge and still give new data a chance?
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - April 18, 2018 Category: Statistics Authors: KristinaWeber
,
RobHemmings
,
ArminKoch Source Type: research
Practical experiences of adopting assurance as a quantitative framework to support decision making in drug development
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - April 10, 2018 Category: Statistics Authors: AdamCrisp
,
SamMiller
,
DouglasThompson
,
NickyBest Source Type: research
